Cipla appoints Peter Lankau as independent director
New Delhi : Drug firm Cipla has appointed Peter Lankau as an independent director on its board with effect.
Lankau is currently a principal of Lankau Consulting LLC. He serves on the Board of Directors of ANI Pharmaceuticals Inc and Phosphagenics Ltd and also on the Board of Advisors of Orchard Venture Partners, a life sciences venture capital firm, Cipla said in a statement.
He was previously Executive Chairman of the Board for Nautilus Neurosciences Inc, Chairman and CEO of Logical Therapeutics Inc and President and CEO of Endo Pharmaceuticals Inc, it added.
Cipla Non-Executive Chairman Y K Hamied said: "Lankau brings with him a deep understanding of the US pharmaceutical market that will help us steer the future thinking of our company for this focus market".
Lankau has over 30 years of management experience in developing and commercialising pharmaceutical products.